MODERN THERAPIES
Brachytherapy: Iodine seeds implantation
Dendritic cells vaccine therapy
Percutaneous Ethanol (Alcohol) Injection therapy
Percutaneous Microwave Coagulation
Radiofrequency ablation
 
TCM Therapy
   Introduction

   Prevention Theory

   Therapeutic Principles
   ICWM
 
Types Of  Cancer
Bladder Cancer
Bone cancer
Breast Cancer
Carcinoid Tumors
Colon Cancer
Esophageal Cancer
Gallbladder Cancer
Gastric Cancer
Hodgkin Lymphoma
Liver Cancer
Lung Cancer
Malignant Mesothelioma
Melanoma
Nasopharyngeal Cancer
Non-hodgkin lymphoma
Osteosarcoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Rectal Cancer
Renal Cancer
Skin cancer
Testicular Cancer
Thymoma and Thymic Carcinoma
Thyroid Cancer
Uterine Cancer
 

 

Prof. Go Visited Our Hospital and Saw the Patients with Pancreatic Cancer in Our Hospital

   
Prof. Go is a famous specialist on Pancreatic disease and nutrition. He was invited to visit our hospital on 27th Oct, 2005. High-tech modalities for cancer ware attracting Porf. Go’s eye. He was very interested in the therapeutic results of a patient with pancreatic cancer and a patient with liver cancer and liver cirrhosis.
 
 
Prof. Go(Middle) and Dr. Niu(Left) are disccusing case


Biosketch of Prof. Vay Liang W. Go, M.D.
Professor of Medicine, David Geffen School of Medicine at UCLA; Associate Director, UCLA-NIH Clinical Nutrition Research Unit; Editor-in-Chief, Pancreas
Dr. Go's research interests, over the last 3 decades, have focused on neuro-hormonal control of gastrointestinal and pancreatic function and metabolism; nutrition and cancer; and cancer prevention. He began his academic career investigating the regulation of human pancreatic exocrine and endocrine secretions and early diagnosis of pancreatic cancer, and subsequently expanded his research work to brain-gut interaction, and nutrition and cancer. From 1975-1985, he co-established and directed the National Cancer Institute Serum Immunodiagnostic Bank Program at the Mayo Clinic. This is the world's largest serum bank used by NCI in evaluating various tumor markers in diagnosing, prognosing and monitoring values in treating the various cancers evaluated by both NIH extramural and intramural programs. During 1985-1988, Dr. Go served simultaneously in three related capacities at the National Institutes of Health, Bethesda, MD: 1) Director, Division of Digestive Diseases and Nutrition at the National Institute of Diabetes and Digestive and Kidney Diseases, 2) Chairman of the Nutrition Coordinating Committee at the Office of the Director of the National Institutes of Health (HIH). In 1988, he joined UCLA Department of Medicine as the Executive Chairman. Since 1996, Dr. GO has focused his creative energies in co-founding the UCLA Center for Human Nutrition with the mission of facilitating interdisciplinary research in nutrition and cancer prevention. Dr. Go has authored and co-authored more than 320 peer-reviewed articles and over 100 editorials, book chapters and review articles, and has co-edited 6 books and trained over 60 fellows and junior faculty, some of whom now provide national and international leadership in gastroenterology and pancreatology..

Selected References

1. Go VLW, Wong DA, Butrum R. Diet, nutrition, and cancer prevention: Where are we going from here? J Nutr 2001;131:3121S-3126S.
2. Boros LG, Lee W-NP, Go VLW. A metabolic hypothesis of cell growth & death in pancreatic cancer. Pancreas 2002;24:26-33.
3. Go VLW and Tache Y. Gastrointestinal Dysfunction and Anorexia: Role of Brain-Gut Axis in: The Control of Food and Fluid Intake in Health and Disease, edited by Michael J. G. Farthing and Dilip Mahalanabis. Nestle Nutrition Workshop Series, Pediatric Program. Lippincott Williams & Wilkins, Philadelphia. 51: 31-44, 2003.
4. Go VLW, Butrum R, Wong DA. Diet, nutrition, and cancer prevention: The postgenomic era. J. Nutr 2003; 133(11). (In press)

 

 
Copyright©Fuda Cancer hospital Guangzhou
Address:No.167.West Xingang Rd,Guangzhou P.C:510300
Tel:020-84105192、84468003  Fax:020-84195515
Email: webmaster@orienttumor.com